2993 related articles for article (PubMed ID: 9143316)
21. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
Koong SL; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
[TBL] [Abstract][Full Text] [Related]
22. Trends in cervical cancer mortality in the Americas.
Robles SC; White F; Peruga A
Bull Pan Am Health Organ; 1996 Dec; 30(4):290-301. PubMed ID: 9041740
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
Thiry N; De Laet C; Hulstaert F; Neyt M; Huybrechts M; Cleemput I
Int J Technol Assess Health Care; 2009 Apr; 25(2):161-70. PubMed ID: 19366497
[TBL] [Abstract][Full Text] [Related]
25. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
Menon A; Devlin NJ; Richardson AK
N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
de Kok IM; van Ballegooijen M; Habbema JD
J Natl Cancer Inst; 2009 Aug; 101(15):1083-92. PubMed ID: 19571256
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
28. [Health economics analysis of colorectal screening].
Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
[TBL] [Abstract][Full Text] [Related]
29. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
Hakulinen T; Andersen A; Malker B; Pukkala E; Schou G; Tulinius H
Acta Pathol Microbiol Immunol Scand Suppl; 1986; 288():1-151. PubMed ID: 3465196
[TBL] [Abstract][Full Text] [Related]
30. A screening programme for cervical cancer that worked.
Hakama M; Louhivuori K
Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
[TBL] [Abstract][Full Text] [Related]
31. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006.
Klint A; Engholm G; Storm HH; Tryggvadóttir L; Gislum M; Hakulinen T; Bray F
Acta Oncol; 2010 Jun; 49(5):578-607. PubMed ID: 20491524
[TBL] [Abstract][Full Text] [Related]
32. [Costs and effects of alternative screening programs against cervical cancer].
Gyrd-Hansen D; Hølund B; Andersen P
Ugeskr Laeger; 1996 Aug; 158(35):4912-5. PubMed ID: 8801698
[TBL] [Abstract][Full Text] [Related]
33. Effect of screening in the Nordic cancer control up to the year 2017.
Hakama M; Hristova L
Acta Oncol; 1997; 36(2):119-28. PubMed ID: 9140427
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of cancer in the United States.
Cresanta JL
Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis.
Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
Eur J Cancer; 2011 Jul; 47(11):1633-46. PubMed ID: 21482103
[TBL] [Abstract][Full Text] [Related]
36. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results.
Storm HH; Engholm G; Hakulinen T; Tryggvadóttir L; Klint A; Gislum M; Kejs AM; Bray F
Acta Oncol; 2010 Jun; 49(5):532-44. PubMed ID: 20491522
[TBL] [Abstract][Full Text] [Related]
37. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Klint A; Bray F; Storm HH
Acta Oncol; 2010 Jun; 49(5):655-64. PubMed ID: 20156116
[TBL] [Abstract][Full Text] [Related]
38. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
39. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Benamouzig R
Endoscopy; 2012 May; 44(5):456-64. PubMed ID: 22531982
[TBL] [Abstract][Full Text] [Related]
40. The incidence of breast cancer: the global burden, public health considerations.
Forbes JF
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-20-S1-35. PubMed ID: 9045313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
